Medicine in Mind, Healing at Heart: Big Data and Its Limits in Compassionate Care

References

1. 1.↵
   1. Gupta A,
   2. Thompson D,
   3. Whitehouse A,
   4. et al

   . Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase. Lancet 2017;389:2473–81.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Golder S,
   2. O'Connor K,
   3. Hennessy S,
   4. Gross R,
   5. Gonzalez-Hernandez G

   . Assessment of beliefs and attitudes about statins posted on Twitter: a qualitative study. JAMA Netw Open 2020;3:e208953.

   OpenUrl
3. 3.↵
   1. Collins R,
   2. Reith C,
   3. Emberson J,
   4. et al

   . Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 2016;388:2532–61.

   OpenUrlCrossRefPubMed
4. 4.↵
   Cholesterol Treatment Trialists' Collaborators. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012;380:581–90.

   OpenUrlCrossRefPubMedWeb of Science